A one-minute look at managed care news during the week of May 4, 2015, including global cancer drug spend, movements in telehealth, and changing behavior to reverse poor health.
This week IMS Health reported that total global cancer drug spending hit the $1 billion mark in 2014, up 10.3% from 5 years earlier. This growth was driven by earlier diagnosis, longer treatment duration, and increased effectiveness of cancer therapies.
Telehealth received a boost this week when UnitedHealth announced that through its coverage for doctor visits via telemedicine, 20 million Americans could access telemedicine and receive coverage for it by next year.
Thomas Morrow, MD, wrote in a contributed article to AJMC.com that behavior modifications are the keys to improving health outcomes. Dr Morrow is just one of AJMC.com's many contributors. You can see more here. If you are interested in becoming an AJMC.com contributor sign up here.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen